Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Robert C. Pordy0
Garen Manvelian0
Date of Patent
February 20, 2024
0Patent Application Number
169912690
Date Filed
August 12, 2020
0Patent Citations
...
Patent Primary Examiner
Patent abstract
The present invention provides methods for reducing or eliminating a patient's need for lipoprotein apheresis therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody. The methods of the present invention are useful for treating patients with hyperlipidemia and related conditions who are currently being treated with a therapeutic regimen comprising lipoprotein apheresis (e.g., LDL apheresis or Lp(a) apheresis).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.